HalliwellBGutterridgeJMC. Free radicals in biology and medicine. Oxford: Oxford University Press, 1989:1–20.
2.
BelchJJFMackayAHillAJenningsPMcCollumP. Oxidative stress is present in atherosclerotic peripheral arterial disease and further increased by diabetes mellitus. Int Angiol1995; 14:385–8.
CurtisMJPugsleyMKWalkerMJA. Endogenous chemical mediators of ventricular arrythmias in ischaemic heart disease. Cardiovasc Res1993; 27:703–19.
5.
LauCSScottNShawJWBelchJJF. Increased activity of oxygen free radicals during reperfusion in patients with peripheral arterial disease undergoing percutaneous peripheral artery balloon angioplasty. Int Angiol1991; 10:244–6.
6.
BolliR. Oxygen derived free radicals and myocardial perfusion injury: an overview. Cardiovascular Drugs Ther1991; 5:24968.
7.
BridgesABMcNeillGPPringleTHBelchJJB. A late increase in free radical activity post myocardial infarction. Euro Heart J1995; 16:899–902.
8.
MartinWJ. Neutrophils kill pulmonary endothelial cells by a hydrogen peroxide dependent pathway. An in vitro model of neutrophil-mediated lung injury. Ann Rev Respir Dis1984; 130:20913.
9.
WitzumJLSteinbergD. Role of oxidised low density lipoprotein in atherogenesis. J Clin Invest1991; 88:1785–92.
10.
BridgesABFisherTCScottNMcLarenMBelchJJF. Circadian rhythm of white cell aggregation and free radical status in healthy volunteers. Free Rad Res Comm1992; 16:8997.
11.
BridgesABScottNAMcNeillGPPringleTHBelchJJB. Circadian variation of white blood cell aggregation and free radical indices in men with ischaemic heart disease. Euro Heart J1992; 13:1632–6.
12.
RossR. The pathogenesis of atherosclerosis; a perspective for the 1990's. Nature1993; 362:801–9.
13.
FreidlHPSmithDJTillGO. Ischaemia-reperfusion in humans appearance of xanthine oxidase activity. Am J Path1990; 136:491.
14.
ZweierJLBroderickRKuppusamyPThompson-GormanSLuttyGA. Determination of the mechanism of free radical generation in human aortic endothelial cells exposed to anoxia and reoxygenation. J Biol Chem1994; 269:24156–62.
15.
XiaYZweierJL. Xanthine oxidase substrate formation triggers and controls free radical generation in post ischaemic heart. J Invest Med1996; 44:A282. (Abstract).
16.
QuyyumiAKGodinDVJamiesonWREKoKMPoostizadehA. Correlation of red cell antioxidant status and heart lung function in swine pretreated with allopurinol. Transplantation1993; 56:37–43.
17.
HopsonSBLustRMSunYSZeriRSMorrisonRF. Otaki M, Chitwood R Jnr. Allopurinol improves myocardial reperfusion in a xanthine oxidase free model. J Natl Med Assoc1995; 87:4804.
18.
SistoTPaajanenHMetsä-KeteläTHarmoinenANordbackITarrkaM. Pretreatment with antioxidants and allopurinol diminishes cardiac onset events in coronary artery bypass grafting. Ann Thorac Surg1995; 59:151923.
19.
RashidMAWiliam-OlssonG. Influence of allopurinol on cardiac complications in open heart operations. Ann Thorac Surg1991; 52:127–30.
GimpelJALahporHRVandermolenAJDamenJ. Reduction of reperfusion injury of human myocardium by allopurinol - a clinical study. Free Rad Biol Med1995; 19:251–5.
22.
JohnsonWDKayserKLBrenowitzJBSaediSF. A randomised controlled trial of allopurinol in coronary bypass surgery. Am Heart J1991; 121:204.
23.
TaggartDPYoungVHooperJKempMWalesbyRWrightJE. Lack of cardioprotective efficacy of allopurinol in coronary artery surgery. Brit Heart J1994; 71:177–81.
24.
O'DellTJHawkinsRDKandelERArancioO. Tests of the role of two diffusible substances in long term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc Nat Acad Sci USA1991; 88:11285–9.
25.
MoorePKBabbedgeRCWallacePGaffenZAHartZL. 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nocioceptive activity in the mouse without increasing blood pressure. Br J Pharmacol1993; 108:296–7.
26.
MoncadaSHiggsA. The L-arginine-nitric oxide pathway. N Engl J Med1993; 329:2002–12.
27.
HibbsJB. Synthesis of nitric oxide from L-arginine: a recently discovered pathway induced by cytokines with anti-tumour and anti-microbial activities. Res Immunol1991; 142:565–9.
28.
MoncadaSPalmerRMJHiggsEA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev1991; 43:10941.
29.
TayehMAMariettaMA. Macrophage oxidation of L-arginine to nitric oxide, nitrite and nitrate. J Biol Chem1989; 264:19654–8.
30.
CalverACollierJMoncadaSVallanceP. Effect of intra-arterial NG-monomethyl-L-arginine in patients with essental hypertension: the nitric oxide dilator system appears abnormal. J Hypertension1992; 10:1025–31.
31.
CelemajerDSSorensonKEGeorgakopoulosDBullCThomasORobinsonJDeanfieldJE. Cigarette smoking is associated with dose related and potentially reversible impairment of endothelium dependent dilatation in healthy young adults. Circulation1993; 88(Part 1):214955.
32.
GoodfellowJRamseyMWLuddingtonLA. Endothelium and inelastic arteries: an early marker of vascular dysfunction in non-insulin dependent diabetes. BMJ1996; 312:744–55.
33.
DrexlerHZeiherAMMeinzerKJustH. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet1991; 338:1546–50.
34.
MoroMADarley-UsmarVMGoddwinDAReadNGZamora-PinoRFeelischM. Paradoxical fate and biological action of peroxynitrite on human platelets. Proc Nat Acad Sci1994; 91:6702–6.
35.
PetrosABenetDVallanceP. Effect of nitric oxide synthesis inhibitors on hypotension in patients with sepsis. Lancet1991; 101:81015.
36.
RadiRBeckmanJSBushKMFreemanBA. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem1991; 266:4244–50.
37.
DijkmansRBilliauA. Interferon-γ lipopolysaccarhide-treated mouse embryonic fibroblasts are killed by a glycolysis/L-arginine dependent process accompanied by depression in mitochondrial respiration. Eur J Biochem1991; 202:151–9.
38.
NguyenTBrunsenDCrepsiCIPenmanBWWishnokJSTannanbaumSR. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Nat Acad Sci1992; 89:30304.
39.
SchiniVBVanhouttePM. Role of L-arginine-nitric oxide pathway in vascular smooth muscle. Eur Heart J1993; 14:S16–21.
40.
Report of a Working Party of the Royal College of Physicians. Smoking and the Young. London: 1992:41–53.
41.
FieldingJ. Smoking: health effects and control. N Eng J Med1985; 313:491–8.
42.
ZhuBQSunYPSieversREIsenbergWMGlantzSAParmleyWW. Passive smoking increases experimental atherosclerosis in cholesterol fed rabbits. J Am Coll Cardiol1993; 21:225–32.
43.
HerderscheeDHijdraAAlgraAKoudstaalPJKappelleLJvan GijnJ. Silent stroke in patients with transient ischaemic attacks or minor stroke: the Dutch TIA Trial Study Group. Stroke1992; 23:12204.
44.
TaylorAEJohnsonDCKazemiH. Environmental tobacco smoke and cardiovascular disease: a position paper from the Council on Cardiopulmonary and Critical Care, American Heart Association. Circulation1992; 86:699702.
45.
ReillyMDelantyNLawsonJAFitzGeraldGA. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation1996; 94:1925.
46.
MuroharaTKugiyamaKOhgushiMSugiyamaSYasueH. Cigarette smoke extracts contracts isolated porcine coronary arteries by superoxide anion mediated degradation of EDRF. Am J Physiol1994; 266:H874–80.
BridgesABScottNAParryGJBelchJJB. Age, sex, cigarette smoking and indices of free radical activity in healthy humans. Eur J Med1993; 2:205–8.
49.
FultonMThomsonMEltonRA. Cigarette smoking, social class and nutrient intake: relevance to coronary heart disease. Eur J Clin Nutr1988; 42:797–803.
50.
LengGCHorrobinDFFowkesFGR. Plasma essential fatty acids, cigarette smoking and dietary antioxidants in peripheral arterial disease. Arterioscler Thromb1994; 14:471–8.
51.
DuthieCGArthurJRJamesPT. Effects of smoking and vitamin E on blood antioxidant status. Am J Clin Nutr Soc1990; 40:273–87.
52.
HarrisonDGOharaY. Physiologic consequences of increased vascular oxidative stresses in hypercholesterolaemia and atherosclerosis: Implications for impaired vasomotion. Am J Cardiol1995; 75:75B-81B.
53.
MinorRLMyersPRGuerreRBatesJNHarrisonDG. Diet induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest1990; 86:210916.
54.
AndersonTJMeredithITYeungACFrieBSelwynAPGanzP. The effect of cholesterol lowering and antioxidant therapy on endothelium dependent coronary vasomotion. N Engl J Med1995; 332:48893.
55.
StroesESGKoomansHAde BruinTWARabelinkTJ. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid lowering medication. Lancet1995; 346:467–71.
56.
GarcíaCEKilcoyneCMCardilloCCannonROQuyymiAAPanzaJA. Evidence that endothelial dysfunction in patients with hypercholesterolaemia is not due to increased extracellular nitric oxide breakdown by superoxide anions. Am J Cardiol1995; 76:1157–61.
57.
GalleJBassengeE. Effects of native and oxidised low density lipoproteins on endothelium independent vasomotion. Basic Res Cardiol1991; 86(S2):127–42.
58.
SchmidtKGraierWFKostnerGMMayerBBohmeEKukvetzWR. Stimulation of soluble guanylate cyclase by endothelium derived relaxing factor is antagonised by oxidised low-density lipoprotein and lysolecithin on soluble guanylyl cyclase. J Cardiavasc Pharmacol1991; 17(suppl 3): S83–8.
59.
KugiyamaKKernsSAMorrisetJDRobertsRHenryPD. Impairment of endothelial dependent relaxation by lysolecithin in modified low density lipoprotein. Nature1990; 344:1602.
60.
SorensonKECelemajerDSGeorgekopoulosD. Impairment of endothelial-dependent dilatation is an early event in children with familial hypercholesterolaemiand is related to lipoprotein(a) level. J Clin Invest1994; 93:505.
61.
VogelRACorrettiMCPlotnickGD. Effect of a single high fat meal on endothelial function in healthy subjects. Am J Cardiol1997; 79:3504.
ShepherdJCobbeSFordI. Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia. N Engl J Med1995; 333:1301–7.
64.
The Scandanavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandanavian Simvastatin Survival Study. Lancet 1994; 344:1383–9.
65.
SacksFMPfefferMAMoyeLA. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med1996; 335:1001–9.
66.
JenningsPEMcLarenMScottNASaniabadiARBelchJJF. The relationship of oxidative stress to thrombotic tendency in type 1 diabetic patients with retinopathy. Diabet Med1991; 8:8605.
67.
WolffSP. Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br Med Bull1993; 49:642–52.
68.
GuiglianoDPaolissoGCerielloA. Oxidative stress and diabetic vascular complications. Diabetes Care1996; 19:257–67.
69.
BowieAOwensDCollinsPJoliasonATomkinGH. Glycosylated low density lipoprotein is more sensitive to oxidation: implications for diabetic patients?Atherosclerosis1993; 102:63–7.
70.
TribeRMPostonL. Oxidative stress and lipids in diabetes: a role in endothelium vasodilator dysfunction?Vascular Med1996; 1:195–206.
71.
LyonsTJKleinRLBaynesJWStevensonHCLopez-VirellaMF. Stimulation of cholesterol ester synthesis in human monocytes derived macrophages by low-density lipoprotein from type 1 (insulin dependent) diabetic patients. The influence of non-enzymatic glycoslation of low-density lipoprotein. Diabetologia1987; 30:916–23.
72.
ElhaddTAJenningsPABelchJJF. Oxidative stress and diabetic complications in young IDDM patients. Diabetes Care1997; 20:1338.
73.
NagasalaYFujiiSKanekoT. Effects of high glucose and sorbitol pathway on lipid peroxidation on erythrocytes. Horm Metab Res1989; 21:275–6.
74.
GeyKFPuskaPJordanPMuserUK. Inverse correlation between plasma vitamin E and mortality from ischaemic heart disease in a cross-cultural epidemiology. Am J Clin Nutr1991; 53:326–34.
75.
Office of Population and Consensus Surveys. Dietary nutritional study of British adults. London: HMSO, 1990.
76.
RiemersmaRAOliverMFEltonRA. Plasma antioxidants and coronary heart disease: vitamin C and E and selenium. Eur J Clin Nutr1990; 4:143–50.
77.
RimmEBStampferMJAscherioA. Vitamin E consumption and the risk of coronary heart disease in man. N Engl J Med1993; 328:14506.
78.
StampferMJHennekensCHMansonJE. Vitamin E consumption and the risk of coronary heart disease in woman. N Engl J Med1993; 328:1444–9.
79.
The Alpha Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med1994; 330:102935.
80.
WaldiusGEriksonVOlssonAG. The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST). Am J Cardiol1994; 74:875–83.
81.
StephansNGParsonsSSchofieldPM. Randomised controlled trial of Vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet1996; 347:781–6.
82.
MacRusySMMuirAMHumeR. Seasonal and climatic variation in cholesterol and vitamin C: effect of vitamin C supplementation. Scot Med J1992; 37:4952.
83.
DavieSJGouldDJYudkinJS. Effect of vitamin C on glycation of proteins. Diabetes1992; 41:167–73
84.
TingHHTiminiFKBolesKSCreagerSJGanzPCreagerMA. Vitamin C improves endothelium dependent vasodilation in patients with non insulin dependent mellitus. J Clin Inv1996; 97:22–8.
ZieglerDUlrichHSchatzH. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4 month randomised multicentre study (DEKAN). Diabetes Care1997; 20:36973.